VIVITRA 440MG

Vivitra 440mg Injection contains Trastuzumab as its active ingredient. It is primarily prescribed for the treatment of HER2-positive breast cancer, a type of cancer characterized by an overexpression of the HER2 protein. In such cases, the HER2 protein acts as a trigger for the rapid growth and multiplication of cancerous cells. Vivitra is also used in the management of metastatic gastric cancer in patients whose tumors show elevated levels of HER2.

HER2-positive breast cancers are known for their aggressive nature. This medication offers targeted therapy by specifically binding to the HER2 receptors and inhibiting the signals responsible for the development and spread of the cancer cells. As a precaution, it is strongly advised to use effective contraception during treatment and to continue using it for at least seven months after the final dose to avoid potential harm to a developing fetus.

Vivitra 440mg is not recommended for children under 18 years of age or for individuals who are suffering from severe respiratory problems or require oxygen therapy. Before starting this treatment, it is essential to inform your physician if you have any existing heart conditions, have experienced shortness of breath, or have previously undergone cancer treatments. Additionally, disclose all medications you are currently taking, including prescription drugs, over-the-counter products, supplements, and herbal remedies, to avoid possible interactions